Honing Biosciences
French tech company | Builders Republic
About
Institut Curie spin-off that developed switchable cell therapies — its RUSH-based CARTune system controlled CAR-T cell activity through biotin dosing, to improve efficacy and reduce toxicity.
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2018
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 2.0 M€
Operations
- Seed · 2020
Investors
Notes
Jugements au BODACC : procédure collective ouverte le 22/11/2022 ; liquidation judiciaire le 09/05/2023.